Acceleration of in vitro dissolution studies of sustained release dosage form of theophylline and in vitro-in vivo evaluations in terms of correlations

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 36, Issue 4, 2011, Pages 243-248

  Ertan, Gökhan ^a   Karasulu, Ercüment ^a   Özgüney, Işik ^a   Karasulu, Yeşim ^a   Apaydin, Şebnem ^a   Kantarci, Gülten ^a   Yurdasiper, Aysu ^a   Ege, Mehmet Ali ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Accelerated release; Correlation; Similarity; Sustained release; Theophylline

Indexed keywords

THEOPHYLLINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG PELLET; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PROCESS CONTROL; QUALITY CONTROL; SUSTAINED RELEASE FORMULATION; TEMPERATURE SENSITIVITY;

ANIMALS; DELAYED-ACTION PREPARATIONS; MALE; RABBITS; SOLUBILITY; THEOPHYLLINE;

EID: 84856304245     PISSN: 03787966     EISSN: 21070180     Source Type: Journal    
DOI: 10.1007/s13318-011-0049-6     Document Type: Article

References (22)

1. Billich A, Aschauer H, Aszodi A, Stuetz A (2004) Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharmaceut 269(1):29-35. doi:10.1016/j.ijpharm.2003.07.013 (Pubitemid 38032821)
2. Breier AR, Paim CS, Steppe M, Schapoval EES (2005) Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets. J Pharm Pharm Sci 8(2): 289-298 (Pubitemid 41519141)
3. Costa P, Sousa Lobo JM (2001) Influence of dissolution medium agitation on release profiles of sustained-release tablets. Drug Dev Ind Pharm 27(8):811-817. doi:10.1081/DDC-100107244 (Pubitemid 33029506)
4. D'Fsouza SS, Jabar AF, DeLuca PP (2005) A model-dependent approach to correlate accelerate with real-time release from biodegradable microspheres. AAPS PharmSciTech 6(4):E553-E564. doi:10.1208/pt060470 (Pubitemid 41645220)
5. Dash AK, Cudworth II GC, (2001) Evaluation of an acetic acid ester of monoglyceride as a suppository base with unique properties. AAPS PharmSciTech 2(3): article 13
6. Ege MA, Karasulu HY, Karasulu E, Ertan G, (2001) A computer program designed for in vitro dissolution kinetics, in vitro.in vivo kinetic correlations and routine application. In: Proceedings of the 4th Central European Symposium on Pharmaceutical Technology, Vienna, Scientia Pharmaceutica Supplement 1 B and 69, pp S127-S128
7. Ertan G, Karasulu HY, Karasulu E, Ege MA, Köse T, Güneri T (2000) A new in vitro/in vivo kinetic correlation method for nitrofurantoin matrix tablet formulations. Drug Dev Ind Pharm 26(7):737-743. doi:10.1081/DDC-100101292 (Pubitemid 30397328)
8. Faergemann J, Wahlstrand B, Hedner T, Johnsson J, Neubert RHH, Nyström L, Maibach H (2005) Pentane-1.5-diol as a percutaneous absorption enhancer. Arch Dermatol Res 297(6):261-265
9. Harrison LI, Mitra AK, Kehe CR, Klinger NM, Wick KA, McCarville SE et al (1993) Kinetics of absorption of a new once-a-day formulation of theophylline in the presence and absence of food. J Pharm Sci 82(6):644-648. doi:10.1002/jps.2600820620 (Pubitemid 23216013)
10. Karasulu E, Akdogu S, Karasulu HY, Aydogdu A, Tuglular I, Ertan G (2003) Improving accuracy of in vitro- in vivo linear correlation using kinetic models for ultra sustained release theophylline tablets. Eur J Drug Metab Pharmacokinet 28(4):301-307 (Pubitemid 38076276)
11. Karasulu E, Apaydn S, Ince I, Tuglular I (2006) Theophylline granule formulation prepared by the wet granulation method: comparison in vitro dissolution profiles and estimation of in vivo plasma concentrations. Eur J Drug Metab Pharmacokinet 31(4): 291-298
12. Lee H, Park SA, Sah H (2005) Surfactant effect upon dissolution patterns of carbamazepine immediate release tablet. Arch Pharm Res 28(1):120-126. doi:10.1007/BF02975147 (Pubitemid 44698777)
13. Moore JW, Flanner HH (1996) Mathematical comparison of dissolution profiles. Pharm Tech 20:64-74 (Pubitemid 126450495)
14. Qiu Y, Garren J, Sammara E, Cao G, Abraham C, Cheskin HS, Engh KR (2003) Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method. J Pharm Sci 92(11):2317-2325. doi:10.1002/jps.10486 (Pubitemid 37356704)
15. Shameed M, Lee H, DeLuca PP (1999) A short-time (Accelerated Release) approach to evaluate peptide release from PLGA depot formulations. AAPS Pharmsci 1(3):E7. doi:10.1208/ps010307
16. Souto EB, Wissing SA, Barbosa CM, Müller RH (2004) Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharmaceut 278(1):71-77. doi:10.1016/j.ijpharm.2004.02.032 (Pubitemid 38670438)
17. The internet drug index for prescription drugs (1995). http://www.rxlist.com
18. Witt C, Kissel T (2001) Morphological characterization of microspheres, films and implants prepared from poly(lactide-coglycolide) and ABA triblock copolymers: is the erosion controlled by degradation swelling or diffusion? Eur J Pharm Biopharm 51(3):171-181. doi:10.1016/S0939-6411(01)00130-8 (Pubitemid 32422094)
19. Woo BH, Konstanski JW, Gebrekidan S, Dani BA, Thanoo BC, DeLuca PP (2001) Preparation, characterization and in vivo evaluation of 120-day poly(D, L-lactide) leuprolide microspheres. J Control Release 75(3):307-315. doi:S0168-3659(01)00403-5 (Pubitemid 32727261)
20. Wu Y, Kildsig O, Ghaly ES (2004) Effect of hydrodynamic environment on tablets dissolution rate. Pharm Dev Technol 9(1):25-37. doi:10.1081/PDT- 120027415 (Pubitemid 38250224)
21. Zackrisson G, Ostling G, Skanderberg B, Anfalt T (1995) Accelerated dissolution rate analysis (ACDRA) for controlled release drugs. Application to Roxiam. J Pharm Biomed Anal 13:377-383
22. Zhang M, Yang Z, Chow LL, Wang CH (2003) Simulation of drug release from biodegradable polymeric microspheres with bulk and surface erosions. J Pharm Sci 92(10):2040-2056. doi: 10.1002/jps.10463 (Pubitemid 37175634)